reference/23645707

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23645707

Outgoing Links

Predicate	Object
contentType	Journal Article\|Validation Study
endingPage	2421
issn	1476-5381 0007-1188
issueIdentifier	14
pageRange	2409-2421
publicationName	British Journal of Pharmacology
startingPage	2409
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fdb95f94008cff51464e99b04994a610 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f2b0ac8e38674f08b0ca4c8db8f64e98 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3b0d9beddbffd53d2722c2299d3b6dd7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0da90a2b5ff1510cec02c42591215e32 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c7378314dfe4ce501be89f604ee744c7
bibliographicCitation	Gbahou F, Cecon E, Viault G, Gerbier R, Jean-Alphonse F, Karamitri A, Guillaumet G, Delagrange P, Friedlander RM, Vilardaga JP, Suzenet F, Jockers R. Design and validation of the first cell-impermeant melatonin receptor agonist. Br J Pharmacol. 2017 Jul;174(14):2409–21. PMID: 28493341; PMCID: PMC5481653.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4617-4850 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8829932975804d8835b4753d39f51b83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53684de7b4260684b84c516df4f4a2f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_001c81e8d32f69c094c9b063818c4f58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a22c83d0f0077b654b653f273a8a125 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5b788986790bfe6dc72d562790ed620 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c58b7896774006e231e7aeea917d575 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8397-5529 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b4c2e97e6e741a30dbcf8d60a619cb7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4007fa86379f8e7e2bea29e33f57000b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4354-1750 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74f175cf19969e76157bde09c09919ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7c4f81bcf2f1a0c108efa89e02714ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_321a5abcd4ab6893d0a8d2e717a1665e
date	2017-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/bph.13856 https://pubmed.ncbi.nlm.nih.gov/PMC5481653 https://pubmed.ncbi.nlm.nih.gov/28493341
isPartOf	https://portal.issn.org/resource/ISSN/1476-5381 https://portal.issn.org/resource/ISSN/0007-1188 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Design and validation of the first cell‐impermeant melatonin receptor agonist
discusses	http://id.nlm.nih.gov/mesh/M0235814 http://id.nlm.nih.gov/mesh/M0018276 http://id.nlm.nih.gov/mesh/M0012508 http://id.nlm.nih.gov/mesh/M0003347 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M000641034 http://id.nlm.nih.gov/mesh/M0007897 http://id.nlm.nih.gov/mesh/M0096696
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007211Q000494 http://id.nlm.nih.gov/mesh/D044094Q000819 http://id.nlm.nih.gov/mesh/D008024 http://id.nlm.nih.gov/mesh/D011758Q000494 http://id.nlm.nih.gov/mesh/D005021Q000494 http://id.nlm.nih.gov/mesh/D015195 http://id.nlm.nih.gov/mesh/D011758Q000138 http://id.nlm.nih.gov/mesh/D007211Q000138 http://id.nlm.nih.gov/mesh/D005021Q000138
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007211Q000737 http://id.nlm.nih.gov/mesh/D013329 http://id.nlm.nih.gov/mesh/D002478 http://id.nlm.nih.gov/mesh/D002232Q000032 http://id.nlm.nih.gov/mesh/D057809 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D015394 http://id.nlm.nih.gov/mesh/D002463 http://id.nlm.nih.gov/mesh/D044094Q000378 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D002232Q000737 http://id.nlm.nih.gov/mesh/D005021Q000737 http://id.nlm.nih.gov/mesh/D011758Q000737
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b6b99bad8a62b52077031a5296434a80 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a6fa188a3f616bedbd0dd7c6bbca7da http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8044 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d6ffd79e575969737603b6b747df1d0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_654c04149b4ef29827d6fdd9bda58c56 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d7bb3ab3115058ecbc7b0ce22221fd1f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_615759d339fa3071ed670d6a5e0f05d5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7bfe9356c56817f4c26dbb6e17bdce80 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ef0bee704b37067907711defe643bf65 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d26f007f0564e0bb0e90099d27af4654 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154699456 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0f2a0b87e0224ce4d92d3416423eabe2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89a78d5903bb5398d127783e6075425a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9fab3be4709e51ce02da57dcd5750b55 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_47dba6d1d17e76a769ec7e51d3f02c0e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a1ec8cf952c48dafc1a3a745cec9d665 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a50383ddd7c98a0489779f07954d52

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID434122256 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4544 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4543

Total number of triples: 96.